Human primary melanoma tumor explants (established in NSG mice) show that both Usp9x DUB activity and SOX2 expression are elevated in metastatic tumors when compared to those with inefficient metastatic activity (Figure 5A). This evidence concerns the gene USP9X and melanoma.